Withdrawal: Makena
Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.
Recent Announcements
Access member care plans in UPMC Health Plan Tapestry Link
Starting Dec. 1, 2026, providers will be able to access SNP care plans within UPMC Health Plan Tapestry Link. Care plans are visible on a member’s chart in multiple locations:Nov. 2026Important Notices
UPMC Health Plan Tapestry Link resources available
UPMC Health Plan Tapestry Link will launch on Tuesday, Dec. 1, 2026. To help ease your transition to the new platform, we have developed the following resources:Nov. 2026Important Notices
Changes to inpatient denial and OBS claim billing
We will soon transition to the Epic® platform. This change will align our claims processing with industry standards by adjudicating claims based on the level of care authorized. As this transition approaches, please keep the following areas in mind:Nov. 2026